Impaired myocardial perfusion reserve in patients with fatty liver disease assessed by quantitative myocardial perfusion magnetic resonance imaging

Circulation Journal

Volumn 76, Issue 9, 2012, Pages 2234-2240

  Nakamori, Shiro ^a   Onishi, Katsuya ^a   Nakajima, Hiroshi ^a   Yoon, Yeonyee Elizabeth ^a   Nagata, Motonori ^a   Kurita, Tairo ^a   Yamada, Tomomi ^a   Kitagawa, Kakuya ^a   Dohi, Kaoru ^a   Nakamura, Mashio ^a   Sakuma, Hajime ^a   Ito, Masaaki ^a  

^a MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Abdominal computed tomography; Cardiac magnetic resonance; Fatty liver; Myocardial perfusion reserve

Indexed keywords

C REACTIVE PROTEIN; GADOLINIUM PENTETATE MEGLUMINE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

AGE; AGED; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORONARY FLOW RESERVE; DISEASE ASSOCIATION; FEMALE; HEART EJECTION FRACTION; HEART LEFT VENTRICLE MASS; HEART MUSCLE BLOOD FLOW; HEART MUSCLE PERFUSION; HEMATOCRIT; HUMAN; MAJOR CLINICAL STUDY; MALE; MUSCLE STRESS; MYOCARDIAL PERFUSION IMAGING; NONALCOHOLIC FATTY LIVER; PREVALENCE; RETROSPECTIVE STUDY; VASCULAR RESISTANCE;

AGED; BLOOD FLOW VELOCITY; FATTY LIVER; FEMALE; FRACTIONAL FLOW RESERVE, MYOCARDIAL; HEART VENTRICLES; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MICROCIRCULATION; MIDDLE AGED; MYOCARDIAL ISCHEMIA; RETROSPECTIVE STUDIES;

EID: 84865481880     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-11-1487     Document Type: Article

References (36)

1. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002; 346: 1221-1231.
2. Targher G, Bertolini L, Padovani R, Zenari L, Zoppini G, Falezza G. Relation of nonalcoholic hepatic steatosis to early carotid atherosclerosis in healthy men: Role of visceral fat accumulation. Diabetes Care 2004; 27: 2498-2500.
3. Brea A, Mosquera D, Martin E, Arizti A, Cordero JL, Ros E. Nonalcoholic fatty liver disease is associated with carotid atherosclerosis: A case-control study. Arterioscler Thromb Vasc Biol 2005; 25: 1045-1050.
4. Targher G, Arcaro G. Non-alcoholic fatty liver disease and increased risk of cardiovascular disease. Atherosclerosis 2007; 191: 235-240.
5. Assy N, Djibre A, Farah R, Grosovski M, Marmor A. Presence of coronary plaques in patients with nonalcoholic fatty liver disease. Radiology 2010; 254: 393-400.
6. Targher G, Bertolini L, Padovani R, Zoppini G, Zenari L, Falezza G. Associations between liver histology and carotid intima-media thickness in patients with nonalcoholic fatty liver disease. Arterioscler Thromb Vasc Biol 2005; 25: 2687-2688.
7. Volzke H, Robinson DM, Kleine V, Deutscher R, Hoffmann W, Ludemann J, et al. Hepatic steatosis is associated with an increased risk of carotid atherosclerosis. World J Gastroenterol 2005; 11: 1848-1853.
8. Villanova N, Moscatiello S, Ramilli S, Bugianesi E, Magalotti D, Vanni E, et al. Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease. Hepatology 2005; 42: 473-480.
9. Yilmaz Y, Kurt R, Yonal O, Polat N, Celikel CA, Gurdal A, et al. Coronary flow reserve is impaired in patients with nonalcoholic fatty liver disease: Association with liver fibrosis. Atherosclerosis 2010; 211: 182-186.
10. Sakuma H, Suzawa N, Ichikawa Y, Makino K, Hirano T, Kitagawa K, et al. Diagnostic accuracy of stress first-pass contrast-enhanced myocardial perfusion MRI compared with stress myocardial perfusion scintigraphy. Am J Roentgenol 2005; 185: 95-102.
11. Ishida N, Sakuma H, Motoyasu M, Okinaka T, Isaka N, Nakano T, et al. Noninfarcted myocardium: Correlation between dynamic firstpass contrast-enhanced myocardial MR imaging and quantitative coronary angiography. Radiology 2003; 229: 209-216.
12. Schwitter J, Nanz D, Kneifel S, Bertschinger K, Buchi M, Knusel PR, et al. Assessment of myocardial perfusion in coronary artery disease by magnetic resonance: A comparison with positron emission tomography and coronary angiography. Circulation 2001; 103: 2230-2235.
13. Nagel E, Klein C, Paetsch I, Hettwer S, Schnackenburg B, Wegscheider K, et al. Magnetic resonance perfusion measurements for the noninvasive detection of coronary artery disease. Circulation 2003; 108: 432-437.
14. Wolff SD, Schwitter J, Coulden R, Friedrich MG, Bluemke DA, Biederman RW, et al. Myocardial first-pass perfusion magnetic resonance imaging: A multicenter dose-ranging study. Circulation 2004; 110: 732-737.
15. Kurita T, Tanabe M, Kitagawa K, Onishi K, Shimpo H, Sakuma H, et al. Vegetation with ventricular septal defect detected by cardiac magnetic resonance imaging. Circ J 2010; 74: 592-593.
16. Kurita T, Matsuoka K, Hoshida K, Nakamori S, Ichikawa Y, Tanigawa T, et al. Unique myocardial fibrosis pattern by late gadolinium enhanced magnetic resonance imaging in a patient with isolated noncompaction of the ventricular myocardium. Circ J 2010; 74: 381-382.
17. Kurita T, Sakuma H, Onishi K, Ishida M, Kitagawa K, Yamanaka T, et al. Regional myocardial perfusion reserve determined using myocardial perfusion magnetic resonance imaging showed a direct correlation with coronary flow velocity reserve by Doppler flow wire. Eur Heart J 2009; 30: 444-452.
18. Nakajima H, Onishi K, Kurita T, Ishida M, Nagata M, Kitagawa K, et al. Hypertension impairs myocardial blood perfusion reserve in subjects without regional myocardial ischemia. Hypertens Res 2010; 33: 1144-1149.
19. Piekarski J, Goldberg HI, Royal SA, Axel L, Moss AA. Difference between liver and spleen CT numbers in the normal adult: Its usefulness in predicting the presence of diffuse liver disease. Radiology 1980; 137: 727-729.
20. Hsu LY, Rhoads KL, Holly JE, Kellman P, Aletras AH, Arai AE. Quantitative myocardial perfusion analysis with a dual-bolus contrast-enhanced first-pass MRI technique in humans. J Magn Reson Imaging 2006; 23: 315-322.
21. Ishida M, Ichihara T, Nagata M, Ishida N, Takase S, Kurita T, et al. Quantification of myocardial blood flow using model based analysis of first-pass perfusion MRI: Extraction fraction of Gd-DTPA varies with myocardial blood flow in human myocardium. Magn Reson Med 2011; 66: 1391-1399.
22. Senturk O, Kocaman O, Hulagu S, Sahin T, Aygun C, Konduk T, et al. Endothelial dysfunction in Turkish patients with non-alcoholic fatty liver disease. Intern Med J 2008; 38: 183-189.
23. Bottcher M, Madsen MM, Refsgaard J, Buus NH, Dorup I, Nielsen TT, et al. Peripheral flow response to transient arterial forearm occlusion does not reflect myocardial perfusion reserve. Circulation 2001; 103: 1109-1114.
24. Bohte AE, van Werven JR, Bipat S, Stoker J. The diagnostic accuracy of US, CT, MRI and 1H-MRS for the evaluation of hepatic steatosis compared with liver biopsy: A meta-analysis. Eur Radiol 2011; 21: 87-97.
25. van Werven JR, Marsman HA, Nederveen AJ, Smits NJ, ten Kate FJ, van Gulik TM, et al. Assessment of hepatic steatosis in patients undergoing liver resection: Comparison of US, CT, T1-weighted dualecho MR imaging, and point-resolved 1H MR spectroscopy. Radiology 2010; 256: 159-168.
26. Kugelmas M, Hill DB, Vivian B, Marsano L, McClain CJ. Cytokines and NASH: A pilot study of the effects of lifestyle modification and vitamin E. Hepatology 2003; 38: 413-419.
27. Yokoyama I, Ohtake T, Momomura S, Yonekura K, Kobayakawa N, Aoyagi T, et al. Altered myocardial vasodilatation in patients with hypertriglyceridemia in anatomically normal coronary arteries. Arterioscler Thromb Vasc Biol 1998; 18: 294-299.
28. Camici PG, Crea F. Coronary microvascular dysfunction. N Engl J Med 2007; 356: 830-840.
29. Erdogan D, Yildirim I, Ciftci O, Ozer I, Caliskan M, Gullu H, et al. Effects of normal blood pressure, prehypertension, and hypertension on coronary microvascular function. Circulation 2007; 115: 593-599.
30. Meyer C, Schwaiger M. Myocardial blood flow and glucose metabolism in diabetes mellitus. Am J Cardiol 1997; 80: 94A-101A.
31. Pitkanen OP, Raitakari OT, Niinikoski H, Nuutila P, Iida H, Voipio-Pulkki LM, et al. Coronary flow reserve is impaired in young men with familial hypercholesterolemia. J Am Coll Cardiol 1996; 28: 1705-1711.
32. Wang L, Jerosch-Herold M, Jacobs DR Jr, Shahar E, Folsom AR. Coronary risk factors and myocardial perfusion in asymptomatic adults: The Multi-Ethnic Study of Atherosclerosis (MESA). J Am Coll Cardiol 2006; 47: 565-572.
33. Davis LE, Hohimer AR, Morton MJ. Myocardial blood flow and coronary reserve in chronically anemic fetal lambs. Am J Physiol 1999; 277: R306-R313.
34. Treasure CB, Klein JL, Vita JA, Manoukian SV, Renwick GH, Selwyn AP, et al. Hypertension and left ventricular hypertrophy are associated with impaired endothelium-mediated relaxation in human coronary resistance vessels. Circulation 1993; 87: 86-93.
35. Chade AR, Brosh D, Higano ST, Lennon RJ, Lerman LO, Lerman A. Mild renal insufficiency is associated with reduced coronary flow in patients with non-obstructive coronary artery disease. Kidney Int 2006; 69: 266-271.
36. Brilla CG, Janicki JS, Weber KT. Impaired diastolic function and coronary reserve in genetic hypertension: Role of interstitial fibrosis and medial thickening of intramyocardial coronary arteries. Circ Res 1991; 69: 107-115.